Eravacycline, an antibacterial drug, repurposed for pancreatic cancer therapy: insights from a molecular-based deep learning model
CONCLUSION: Our study highlights the potential of drug repurposing for cancer treatment using ML. Eravacycline showed promising results in inhibiting cancer cell proliferation, migration and inducing apoptosis in PDAC. These findings demonstrate that our developed ML drug repurposing models can be applied to a wide range of new oncology therapeutics, to identify potential anti-cancer agents. This highlights the potential and presents a promising approach for identifying new therapeutic options.PMID:38647152 | PMC:PMC11033730 | DOI:10.1093/bib/bbae108
Source: Briefings in Bioinformatics - Category: Bioinformatics Authors: Adi Jabarin Guy Shtar Valeria Feinshtein Eyal Mazuz Bracha Shapira Shimon Ben-Shabat Lior Rokach Source Type: research
More News: Adenocarcinoma | Bioinformatics | Cancer | Cancer & Oncology | Cancer Therapy | Chemotherapy | Learning | Pancreas | Pancreatic Cancer | Study | Universities & Medical Training